The oncology research landscape has benefited tremendously from high-throughput genomic sequencing technologies. However, cancer is a complex disease, and many complex variants, methylation, and transcript isoforms are inaccessible with short-read sequencing and microarray approaches.
Download this white paper to explore how scientists have used Oxford Nanopore sequencing to advance their research in precision oncology and uncover previously hidden genomic regions.
Top Image Credit:
©iStock, alanphillips
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this Issue
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
Compact, Powerful, and now Mass Spec-Connected for Superior Analytical Performance
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
